Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

about

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

Item

http://www.wikidata.org/entity/Q47106144

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

@en

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

@nl

type

Item

label

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

@en

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

@nl

prefLabel

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

@en

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

@nl

P1476

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

@en

P2093

Jianfei Wang

http://www.w3.org/2001/XMLSchema#string

Lili Qin

http://www.w3.org/2001/XMLSchema#string

Lin Lin

http://www.w3.org/2001/XMLSchema#string

Wenjun Qin

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic Retinopathy and Clinical Parameters Favoring the Presence of Diabetic Nephropathy could Predict Renal Outcome in Patients with Diabetic Kidney Disease.

C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway.

Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy.

Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.

Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.

Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis.

Complication in diabetic nephropathy.

Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.

Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.

N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models.

P304

5012-5016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29201206

http://www.w3.org/2001/XMLSchema#string

P932

5704275

http://www.w3.org/2001/XMLSchema#string